Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Change in Acquisitions & Divestments (2016 - 2025)

Tg Therapeutics (TGTX) has 5 years of Change in Acquisitions & Divestments data on record, last reported at $30.0 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 59.29% year-over-year to $30.0 million; the TTM value through Dec 2025 reached $237.5 million, down 23.61%, while the annual FY2025 figure was $237.5 million, 23.61% down from the prior year.
  • Change in Acquisitions & Divestments reached $30.0 million in Q4 2025 per TGTX's latest filing, down from $77.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $92.3 million in Q3 2024 and bottomed at $16.0 million in Q1 2023.
  • Average Change in Acquisitions & Divestments over 4 years is $51.1 million, with a median of $49.3 million recorded in 2025.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 358.76% in 2024, then plummeted 59.29% in 2025.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $20.3 million in 2022, then grew by 16.81% to $23.7 million in 2023, then surged by 211.26% to $73.7 million in 2024, then crashed by 59.29% to $30.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $30.0 million in Q4 2025, $77.8 million in Q3 2025, and $49.3 million in Q2 2025.